ReviewClinics (Sao Paulo, Brazil)2023

Programmed cell death-1 and its ligands: Current knowledge and possibilities in immunotherapy.

Bojana Gutic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.